Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500115353) titled 'The effect of sugammadex on muscle relaxation recovery and pulmonary complications in elderly patients with sarcopenia after hip surgery' on Dec. 25, 2025.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Anhui NO.2 Provincial People's Hospital
Condition:
Sarcopenia
Intervention:
Sugammadex Sodium Group (Group S):After the operation, patients in Group S were transferred to the post-anesthesia care unit (PACU) and received an intravenous injection of sugammadex sodium at a dose of 2 mg/kg.
Recruitment Status: Recruiting
Phase: 1
Date of First Enrollment: 2025-12-30
Target Samp...